Prognozy (mln) dla Aarti Drugs Limited
| Okres |
2024-03-31 |
2025-03-31 |
2026-03-31 |
2027-03-31 |
2028-03-31 |
| Przychód (średnia) |
26,100.00 |
26,100.00 |
23,000.00 |
26,883.00 |
30,271.00 |
| Przychód Δ r/r |
0.00% |
0.00% |
-11.88% |
16.88% |
12.60% |
| Przychód (min) |
26,100.00 |
26,100.00 |
23,000.00 |
26,883.00 |
30,271.00 |
| Przychód (max) |
26,100.00 |
26,100.00 |
23,000.00 |
26,883.00 |
30,271.00 |
| EBITDA (średnia) |
3,850.06 |
3,693.21 |
3,254.56 |
3,804.01 |
4,283.42 |
| EBIT (średnia) |
3,279.57 |
3,141.65 |
2,768.50 |
3,235.90 |
3,643.71 |
| EBIT % |
12.57% |
12.04% |
12.04% |
12.04% |
12.04% |
| Zysk netto (średni) |
1,719.28 |
1,719.28 |
1,425.07 |
2,133.01 |
2,601.90 |
| Zysk netto % |
6.59% |
6.59% |
6.20% |
7.93% |
8.60% |
| EPS (średnia) |
18.70 |
18.70 |
15.50 |
23.20 |
28.30 |
| Liczba analityków (Przychody) |
1 |
1 |
1 |
1 |
1 |
| Liczba analityków (EPS) |
1 |
1 |
1 |
1 |
1 |
| symbol |
AARTIDRUGS.BO |
AARTIDRUGS.BO |
AARTIDRUGS.BO |
AARTIDRUGS.BO |
AARTIDRUGS.BO |